Arsenic Trioxide Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Arsenic Trioxide Injection (injection) from Ingenus Pharmaceuticals LLC with status To Be Discontinued. The shortage was first posted on 02/24/2026.
Shortage Details
- Status
- To Be Discontinued
- Company
- Ingenus Pharmaceuticals LLC
- Package NDC
- 50742-438-10
- Dosage Form
- Injection
- Presentation
- Arsenic Trioxide, Injection, 1 mg/1 mL (NDC 50742-438-10)
- Initial Posting
- 02/24/2026
- Revised Date